Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)
Hong Kong · Delayed Price · Currency is HKD 254.00
-49.20 (-16.23%)
Sep 30, 2026, 4:08 PM HKT
HKG:2526 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | -121.68 | -67.14 | -43.38 | -56.12 |
Depreciation & Amortization | 8.3 | 10.9 | 13.63 | 7.51 |
Other Amortization | 0.12 | 0.12 | - | - |
Loss (Gain) From Sale of Assets | 0.04 | -2.2 | -0.18 | 0.08 |
Loss (Gain) From Sale of Investments | 13.06 | 9.57 | 2.07 | 1.01 |
Loss (Gain) on Equity Investments | -0.02 | -0.03 | 0.1 | 0 |
Stock-Based Compensation | 0.04 | 0.06 | 0.1 | 6.44 |
Other Operating Activities | 12.44 | 0.3 | 19.2 | 14.85 |
Change in Accounts Receivable | -52.42 | -28.52 | -28.09 | -1.02 |
Change in Inventory | -17.55 | -0.51 | 4.2 | -2.44 |
Change in Accounts Payable | 23.07 | 15.08 | 4.19 | -0.28 |
Change in Other Net Operating Assets | -17.77 | 11.83 | -1.61 | -17.43 |
Operating Cash Flow | -152.37 | -50.54 | -29.78 | -47.4 |
Operating Cash Flow Growth | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -3.71 | -7.47 | -24.2 | -24.22 |
Sale of Property, Plant & Equipment | - | - | 0.24 | - |
Divestitures | - | -0.11 | - | - |
Sale (Purchase) of Intangibles | -0.16 | -0.16 | -1.05 | - |
Investment in Securities | 40.99 | 9.84 | 23.66 | -92.84 |
Other Investing Activities | - | - | 21 | - |
Investing Cash Flow | 37.11 | 2.1 | 19.66 | -117.06 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Short-Term Debt Issued | - | - | 10 | - |
Total Debt Issued | 50 | - | 10 | - |
Short-Term Debt Repaid | - | -10 | - | - |
Long-Term Debt Repaid | - | -1.83 | -2.73 | -2.2 |
Lease Payments | -2.11 | -1.83 | -2.73 | -2.2 |
Total Debt Repaid | -7.11 | -11.83 | -2.73 | -2.2 |
Net Debt Issued (Repaid) | 42.89 | -11.83 | 7.28 | -2.2 |
Issuance of Common Stock | 671.27 | 60 | - | 170.15 |
Other Financing Activities | -9.47 | -3.97 | -0.47 | -3.97 |
Financing Cash Flow | 704.69 | 44.2 | 6.81 | 163.98 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Cash Flow | 577.63 | -4.23 | -3.32 | -0.47 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -156.08 | -58 | -53.98 | -71.61 |
Free Cash Flow Growth | - | - | - | - |
Free Cash Flow Margin | -85.15% | -35.28% | -76.72% | -135.52% |
Free Cash Flow Per Share | -1.88 | -0.72 | -0.68 | -0.94 |
Levered Free Cash Flow | - | -49.35 | -63.77 | - |
Unlevered Free Cash Flow | - | -48.99 | -50.52 | - |
Free Cash Flow After Leases | -158.2 | -59.83 | -56.7 | -73.81 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 0.7 | 0.55 | 0.47 | 0.26 |
Cash Income Tax Paid | - | - | 0.03 | - |
Change in Working Capital | -64.66 | -2.12 | -21.31 | -21.17 |